|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation of kefir as a potential probiotic on growth performance,serum biochemistry and immune responses in broiler chicks显示文摘This experiment was conducted to evaluate the effect of milk or molasses kefir as a probiotic on growth performance, carcass traits, serum biochemistry and humoral immune responses in broiler chickens. A total of 192 one-d-old as hatched broiler chicks(Ross 308) were randomly allotted to 4 treatments, each with 4 replicate pens of 12 chicks. The following treatments were applied: 1) a basal diet(C) and normal drinking water, 2) 2% milk kefir in drinking water, 3) 2% molasses kefir in drinking water, and 4) the diet C supplemented with commercial probiotic. At d 42, eight birds per treatment were killed for determination of carcass traits. Broilers at 28 days of age were bled for measuring antibody titers against Newcastle disease virus(NDV) and avian influenza virus(AIV), at 30 days of age for antibody titers against sheep red blood cell(SRBC), and at 42 days of age for biochemical analysis. Supplementing 2%milk kefir increased body weight of broilers at 28 and 42 days of age(P < 0.05). Supplementing 2%molasses kefir improved feed conversation ratio(FCR) of broilers during growth period(P < 0.05), but FCR of broilers in other periods was not affected. Daily feed intake, internal organ weights, and carcass traits were not influenced by the treatments except for small intestine and ceca length. Small intestinal length significantly decreased in broilers supplemented with milk and molasses kefir(P < 0.05). Molasses kefir supplementation significantly(P < 0.05) increased antibody titer against SRBC at 31 days of age but other immune related parameters were not statistically different among treatments. Biochemical parameters including serum protein, albumin, and triglyceride concentrations were not statistically(P> 0.05) influenced. Broilers supplemented with molasses kefir, had a significantly lower concentration of serum total cholesterol, low density lipoprotein cholesterol and elevated high density lipoprotein cholesterol at 42 days of age(P < 0.05). In conclusion, the results indicated that inclusion of 2% milk kefir in drinking water would improve growth performance of broiler chickens. | Majid Toghyani Seyed kazem Mosavi Mehrdad Modaresi Nasir Landy | 2015 | Animal Nutrition2015，，4： | 6 |
| 2 | Role of platelet-albumin-bilirubin score in predicting re-bleeding after band ligation for acute variceal hemorrhage显示文摘Platelet-albumin-bilirubin(PALBI)score was proposed by Roayaie et al with modification of previously studied albumin-bilirubin score to include platelet as an indicator of portal hypertension in 2015.Predictive value of this score was recently tested by Elshaarawy et al for re-bleeding in patients presenting with acute variceal hemorrhage.We did a similar study at our center(n=170)to look at incidence of re-bleeding after band ligation defined as drop in 2 units of hemoglobin and witnessed melena or hematemesis within 2 wk of the procedure.We calculated PALBI scores for all patients based on lab values prior to the procedure.Of 25.3%had re-bleeding episodes,area under receiver operating characteristic curve for PALBI as predictor of re-bleeding was 0.601(95%confidence interval:0.502-0.699).PALBI score showed moderate accuracy at predicting re-bleeding in our population. | Muhammad S Faisal Tavankit Singh Hina Amin Jamak Modaresi Esfeh | 2020 | World Journal of Hepatology2020，12，10： | 3 |
| 3 | Weight loss interventions in living donor liver transplantation as a tool in expanding the donor pool: A systematic review and metaanalysis显示文摘BACKGROUND With increasing rates of liver transplantation and a stagnant donor pool,the annual wait list removals have remained high.Living donor liver transplantation(LDLT)is an established modality in expanding the donor pool and is the primary method of liver donation in large parts of the world.Marginal living donors,including those with hepatic steatosis,have been used to expand the donor pool.However,due to negative effects of steatosis on graft and recipient outcomes,current practice excludes overweight or obese donors with more than 10%macro vesicular steatosis.This has limited a potentially important source to help expand the donor pool.Weight loss is known to improve or resolve steatosis and rapid weight loss with short-term interventions have been used to convert marginal donors to low-risk donors in a small series of studies.There is,however,a lack of a consensus driven standardized approach to such interventions.AIM To assess the available data on using weight loss interventions in potential living liver donors with steatotic livers and investigated the feasibility,efficacy,and safety of using such donors on the donor,graft and recipient outcomes.The principal objective was to assess if using such treated donor livers,could help expand the donor pool.METHODS We performed a comprehensive literature review and meta-analysis on studies examining the role of short-term weight loss interventions in potential living liver donors with hepatic steatosis with the aim of increasing liver donation rates and improving donor,graft,and recipient outcomes.RESULTS A total of 6 studies with 102 potential donors were included.Most subjects were males(71).All studies showed a significant reduction in body mass index postintervention with a mean difference of-2.08(-3.06,1.10,I2=78%).A significant reduction or resolution of hepatic steatosis was seen in 93 of the 102(91.2%).Comparison of pre-and post-intervention liver biopsies showed a significant reduction in steatosis with a mean difference of-21.22(-27.02,-15.43,I2=56%).The liver donation rates post-intervention was 88.5(74.5,95.3,I2=42%).All donors who did not undergo LDLT had either recipient reasons or had fibrosis/steatohepatitis on post intervention biopsies.Post-operative biliary complications in the intervention group were not significantly different compared to controls with an odds ratio of 0.96[(0.14,6.69),I2=0].The overall post-operative donor,graft,and recipient outcomes in treated donors were not significantly different compared to donors with no steatosis.CONCLUSION Use of appropriate short term weight loss interventions in living liver donors is an effective tool in turning marginal donors to low-risk donors and therefore in expanding the donor pool.It is feasible and safe,with comparable donor,graft,and recipient outcomes,to non-obese donors.Larger future prospective studies are needed. | Sushrut Trakroo Nakul Bhardwaj Rajat Garg Jamak Modaresi Esfeh | 2021 | World Journal of Gastroenterology2021，27，24： | 2 |
| 4 | The Role of Rifaximin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis显示文摘 | Mohamad A. Hanouneh Ibrahim A. Hanouneh Jana G. Hashash Ryan Law Jamak Modaresi Esfeh Rocio Lopez Nyla Hazratjee Thomas Smith Nizar N. Zein | 2012 | Journal of Clinical Gastroenterology2012，，8： | 2 |
| 5 | Epstein-Barr virus-associated smooth muscle tumors in immunocompromised patients:Six case reports显示文摘BACKGROUND Epstein-Barr virus associated smooth muscle tumor(EBV-SMT)is a rare oncological entity.However,there is an increasing incidence of EBV-SMTs,as the frequency of organ transplantation and immunosuppression grows.EBV-SMT diagnosis relies on histopathology and immunochemical staining to distinguish it from post-transplant lymphoproliferative disorder(PTLD).There is no clear consensus on the treatment of EBV-SMTs.However,surgical resection,chemotherapy,radiation therapy,and immunosuppression reduction have been explored with varying degrees of success.CASE SUMMARY Our case series includes six cases of EBV-SMTs across different age groups,with different treatment modalities,adding to the limited existing literature on this rare tumor.The median latency time between immunosuppression and disease diagnosis is four years.EBV-SMTs present with variable degrees of aggressiveness and seem to have worse clinical outcomes in patients with tumor multiplicity and worse immunocompetency.CONCLUSION It is imperative to continue building on this knowledge and keeping EBV-SMTs on the differential in immunocompromised individuals. | Afshin A Khan Bassam N Estfan Anirudh Yalamanchali Djibril Niang Erica C Savage Clifton G Fulmer Hailey L Gosnell Jamak Modaresi Esfeh | 2022 | World Journal of Clinical Oncology2022，13，6： | 2 |
| 6 | Cytotoxicity effects of Cd Se quantum dots on testis development of laboratory mice显示文摘 | Valipoor A Parivar K Modaresi M | 2013 | Optoelectronics and Advanced MaterialsRapid Communications2013，7，34： | 1 |
| 7 | Which is ac- cess suitable for a solitary upper pole renal stone? A possible novel criterion 显示文摘 | Aghamir S M Modaresi S S Aloosh M etal | 2012 | Minerva Urol Nefrol2012，64，1： | 1 |
| 8 | Oxidative stress in chronic kidney disease显示文摘 | Modaresi A Nafar M Sahraei Z | 2015 | Iran J Kidney Dis2015，9，3： | 1 |
| 9 | Totally Tubeless Percu-taneous Nephrolithotomy for Upper Pole Renal Stone Using SubcostalAc-cess显示文摘 | Aghamir SM Modaresi SS Mehdi Ah | | 0，，04： | 1 |
| 10 | Carotid plaque chara cterization by duplex scanning:observer error may undermine current clinical trials显示文摘 | Arnold JA Modaresi KB Thomas N | | 0，，1： | 1 |
| 11 | Carotid plaque characterization by duplex scanning:observer error may undermine current clinical trials显示文摘 | Arnold J Modaresi K Thomas N | 1999 | Stroke1999，30，1： | 1 |
| 12 | 神经系统疾病儿童的血铅水平调查:单中心初步研究(英文)显示文摘目的儿童铅中毒具有很大的潜在危害。慢性低水平铅暴露会导致学习障碍及行为问题,如腹痛,失眠,多动,生长发育落后,听力损失,上肢无力。该研究旨在调查神经系统疾病儿童的血铅水平,并与健康儿童作比较。方法100名患有神经系统疾病的1~10岁儿童作为研究对象。100名年龄和性别匹配的健康儿童作为对照。采用火焰原子吸收光谱法检测血铅含量。结果神经系统疾病组儿童的平均血铅含量显著高于对照组,差异有显著性(113.2±47.5μg/Lvs84.7±38.0μg/L;P<0.01)。神经系统疾病组和对照组分别有44%和19%的儿童血铅超标(>100μg/L)。结论儿童血铅水平增高可能与神经系统疾病有关。建议对患神经系统疾病的儿童常规作血铅测定。 | Touran MAHMOUDIAN Mobamadreza MODARESI Ali ZAREI Parinaz POURSAFA Roya KELISHADI | 2009 | 中国当代儿科杂志2009，11，11： | 1 |
| 13 | Simplified retropubic prostatectomy technique:faster and not more hemorrhagic显示文摘 | Ghasem Mohseni M Modaresi S Hosseini S R | | 0，，02： | 1 |
| 14 | Totally tube- less percutaneous nephrolithotomy for upper pole renal stone using subcostal access显示文摘 | Aqhamir SM Modaresi SS Aloosh M | 2011 | J Endourol2011，25，4： | 1 |
| 15 | Oxidative stress in chronic kidney disease 显示文摘 | Modaresi A Nafar M Sahraei Z | 2015 | Iran J Kidney Dis2015，9，3： | 1 |
| 16 | Effect of pulp inflammation onnerve impulse quality with or without anesthesia 显示文摘 | Modaresi J Dianat O Soluti A | 2008 | J Endod2008，34，43： | 1 |
| 17 | Effect of pulp inflammation on nerve impulse quality with or without anesthesia 显示文摘 | Modaresi J Dianat O Soluti A | 2008 | J Endod2008，34，4： | 1 |
| 18 | An objective method for grading ultrasound images of carotid artery plaques显示文摘 | Andrew Arnold Peter Taylor Robin Poston Kamran Modaresi Soundrie Padayachee | 2001 | Ultrasound in Medicine & Biology2001，，8： | 1 |
| 19 | Effect of magnetic iron oxide nanoparticles on pregnancy and testicular development of mice显示文摘 | Noori A Parivar K Modaresi M | 2011 | African Journal of Biotechnology2011，10，7： | 1 |
| 20 | Effect of magnetic iron oxide nanoparticles on pregnancy and testicular development of mice显示文摘 | Noori A Parivar K Modaresi M Messripour M Yousefi MH Amiri GR | 2013 | Afr J Biotechnol2013，10，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员